CCG-4986 is a drug which is the first non-peptide compound discovered that acts as a selective inhibitor of the

regulator of G protein signalling Regulators of G protein signaling (RGS) are protein structural domains or the proteins that contain these domains, that function to activate the GTPase activity of heterotrimeric G-protein α-subunits. RGS proteins are multi-functional, GTPase- ...

protein subtype

RGS4 Regulator of G protein signaling 4 also known as RGP4 is a protein that in humans is encoded by the ''RGS4'' gene. RGP4 regulates G protein signaling. Function Regulator of G protein signalling (RGS) family members are regulatory molecules that ...

. Regulators of G protein signalling are proteins which act to limit and shorten the response produced inside a cell following activation of a

G protein-coupled receptor G protein-coupled receptors (GPCRs), also known as seven-(pass)-transmembrane domain receptors, 7TM receptors, heptahelical receptors, serpentine receptors, and G protein-linked receptors (GPLR), form a large group of evolutionarily-related p ...

. Since different RGS subtypes are expressed in different tissues and are associated with particular receptors, this makes it possible for selective inhibitors of RGS proteins to be developed, which should be able to enhance the activity of a particular receptor in a defined target tissue, but not elsewhere in the body.

References

Experimental drugs Chloroarenes Nitrobenzenes {{Pharm-stub